Kynurenic acid (KA), an endogenous product of
L-tryptophan metabolism in the
kynurenine pathway, regulates adipose tissue energy homeostasis and
inflammation. However, its role in
palmitate-induced
insulin resistance and detailed underlying mechanisms in skeletal muscles and adipose tissues are unclear. Herein, we report that KA ameliorated
palmitate-induced
inflammation and
insulin resistance in differentiated C2C12 and 3T3-L1 cell lines as well as soleus skeletal muscle and subcutaneous adipose tissues in mice.
Palmitate-induced inflammatory markers, such as nuclear factor κB translocation, inhibitory κBα phosphorylation, pro-inflammatory
cytokine expression, and impaired
insulin signaling, were markedly attenuated by KA both in vitro and in vivo. KA significantly increased
AMP-activated protein kinase (AMPK) phosphorylation and
sirtuin 6 (SIRT6) expressions in C2C12 myocytes and 3T3-L1 adipocytes and skeletal muscle and adipose tissues of mice.
siRNA-mediated AMPK or SIRT6 inhibition significantly mitigated the suppressive effects of KA on
palmitate-induced
inflammation and
insulin resistance. KA significantly stimulated expression of genes involved in
fatty acid oxidation in C2C12 myocytes and skeletal muscle of mice. Moreover, KA inhibits lipogenesis in 3T3-L1 adipocytes. AMPK or SIRT6
siRNA markedly reversed these changes. The
siRNA targeting Gpr35 abrogated the effects of KA on AMPK phosphorylation in C2C12 myocytes and 3T3-L1 adipocytes, except SIRT6 expression. It has therefore been shown that KA could potentially alleviate
inflammation and
insulin resistance in skeletal muscle and adipose tissues through Gpr35/AMPK and SIRT6-mediated pathways.